3D Medicines and CATUG Biotech Forge Strategic Alliance in mRNA-LNP Innovation
China-based 3D Medicines (HKG: 1244) has entered into a strategic cooperation framework agreement with CATUG Biotechnology....
CATUG Biotechnology
CATUG Biotechnology Secures Nearly RMB 100 Million in Latest Financing Round to Expand Globally
CATUG Biotechnology, a cutting-edge company in the nucleic acid and gene therapy sector, has announced...
CATUG Biotechnology Partners with PersonGen to Advance Global CAR-T Cell Therapies
China-based CATUG Biotechnology (Suzhou) Co., Ltd. has entered into a partnership with fellow Suzhou firm...
CATUG Biotechnology Partners with Carcell Biopharma to Advance Nucleic Acid Drug Development
CATUG Biotechnology (Suzhou) Co., Ltd, a Chinese biotechnology company, has entered into a partnership with...
CATUG Biotechnology Partners with Duoning to Advance mRNA Industrialization
China-based CATUG Biotechnology (Suzhou) Co., Ltd has entered into a partnership with compatriot firm Shanghai...